Drug recall · May 29, 2024
Phenylephrine in 0.9% Sodium Chloride Injection Preservative Free recall
Why: Labeling: Label mix-up - ephedrine syringes mislabeled as phenylephrine.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Phenylephrine in 0.9% Sodium Chloride Injection Preservative Free, 100mcg/mL, 5mL syringe, Rx only, Hikma Injectables USA Inc, 36 Stults Road, Dayton, NJ 08810, NDC 63037-123-25
- Lots / codes
Lot #: 240310003D, Exp 6/4/2024
- Company
- Hikma Injectables USA Inc, Dayton, NJ
- Distribution
- CO, GA, PA, SD, WA
- Initiated
- April 29, 2024 · Voluntary: Firm initiated
- Classified
- May 23, 2024
- Reported
- May 29, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Phenylephrine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.